...
search icon
tbph-img

Theravance Biopharma Inc Share Price

TBPH
NMQ
$20.38
+$0.37
(1.85%)
1D
Industry: Pharmaceuticals Sector: Health Care

Theravance Biopharma Inc Analyst Forecast

Theravance Biopharma Inc Share Price Chart

Theravance Biopharma Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.01B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
35.1053
Volume info-icon
This is the total number of shares traded during the most recent trading day.
171.60K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.14
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$7.9 L
$20.79 H
$20.38

About Theravance Biopharma Inc, Common Stock

Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). Its late-stage investigational once-daily norepinephrine reuptake inhibitor, Ampreloxetine is in the development for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California. more

Industry: PharmaceuticalsSector: Health Care

Theravance Biopharma Inc Stock Returns

Time FrameTBPHSectorS&P500
1-Week Return5.09%-1%-0.35%
1-Month Return14.15%1.08%1.9%
3-Month Return42.52%9.43%4.73%
6-Month Return71.76%16.01%10.87%
1-Year Return137.09%10.35%16.88%
3-Year Return74.91%15.52%73.95%
5-Year Return8.28%32.15%82.73%
10-Year Return41.11%132.93%269.09%

Theravance Biopharma Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue71.86M55.31M51.35M57.42M64.38M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":76.97,"profit":true},{"date":"2022-12-31","value":71.46,"profit":true},{"date":"2023-12-31","value":79.91,"profit":true},{"date":"2024-12-31","value":89.6,"profit":true}]
Cost of Revenue260.95M193.66M63.39M40.62M6.01M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":74.21,"profit":true},{"date":"2022-12-31","value":24.29,"profit":true},{"date":"2023-12-31","value":15.57,"profit":true},{"date":"2024-12-31","value":2.3,"profit":true}]
Gross Profit71.86M(138.35M)(12.05M)16.80M64.38M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-192.53,"profit":false},{"date":"2022-12-31","value":-16.76,"profit":false},{"date":"2023-12-31","value":23.38,"profit":true},{"date":"2024-12-31","value":89.6,"profit":true}]
Gross Margin100.00%(250.12%)(23.46%)29.26%100.00%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-250.12,"profit":false},{"date":"2022-12-31","value":-23.46,"profit":false},{"date":"2023-12-31","value":29.26,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses369.48M119.44M79.91M72.84M111.33M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":32.33,"profit":true},{"date":"2022-12-31","value":21.63,"profit":true},{"date":"2023-12-31","value":19.71,"profit":true},{"date":"2024-12-31","value":30.13,"profit":true}]
Operating Income(297.63M)(257.78M)(91.96M)(56.03M)(46.95M)[{"date":"2020-12-31","value":-29762700000,"profit":false},{"date":"2021-12-31","value":-25778400000,"profit":false},{"date":"2022-12-31","value":-9195700000,"profit":false},{"date":"2023-12-31","value":-5603500000,"profit":false},{"date":"2024-12-31","value":-4694900000,"profit":false}]
Total Non-Operating Income/Expense(47.47M)(53.22M)1.32M15.48M4.67M[{"date":"2020-12-31","value":-306.65,"profit":false},{"date":"2021-12-31","value":-343.79,"profit":false},{"date":"2022-12-31","value":8.51,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":30.17,"profit":true}]
Pre-Tax Income(303.34M)(265.22M)(92.81M)(49.27M)(44.61M)[{"date":"2020-12-31","value":-30334300000,"profit":false},{"date":"2021-12-31","value":-26522199900,"profit":false},{"date":"2022-12-31","value":-9281500000,"profit":false},{"date":"2023-12-31","value":-4926900000,"profit":false},{"date":"2024-12-31","value":-4461400000,"profit":false}]
Income Taxes(8.52M)(151.00K)9.00K5.92M11.80M[{"date":"2020-12-31","value":-72.18,"profit":false},{"date":"2021-12-31","value":-1.28,"profit":false},{"date":"2022-12-31","value":0.08,"profit":true},{"date":"2023-12-31","value":50.19,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes(294.82M)(265.07M)(92.82M)(55.19M)(56.42M)[{"date":"2020-12-31","value":-29482300000,"profit":false},{"date":"2021-12-31","value":-26507099900,"profit":false},{"date":"2022-12-31","value":-9282400000,"profit":false},{"date":"2023-12-31","value":-5519300000,"profit":false},{"date":"2024-12-31","value":-5641800000,"profit":false}]
Income From Continuous Operations(278.02M)(199.43M)(92.82M)(60.94M)(56.42M)[{"date":"2020-12-31","value":-27801700000,"profit":false},{"date":"2021-12-31","value":-19942600000,"profit":false},{"date":"2022-12-31","value":-9282400000,"profit":false},{"date":"2023-12-31","value":-6093900000,"profit":false},{"date":"2024-12-31","value":-5641800000,"profit":false}]
Income From Discontinued Operations16.81M65.64M964.96M--[{"date":"2020-12-31","value":1.74,"profit":true},{"date":"2021-12-31","value":6.8,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(278.02M)(199.43M)872.13M(55.19M)(56.42M)[{"date":"2020-12-31","value":-31.88,"profit":false},{"date":"2021-12-31","value":-22.87,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-6.33,"profit":false},{"date":"2024-12-31","value":-6.47,"profit":false}]
EPS (Diluted)(4.48)(2.95)(0.67)(0.97)(0.63)[{"date":"2020-12-31","value":-448,"profit":false},{"date":"2021-12-31","value":-295,"profit":false},{"date":"2022-12-31","value":-67,"profit":false},{"date":"2023-12-31","value":-97,"profit":false},{"date":"2024-12-31","value":-62.91,"profit":false}]

Theravance Biopharma Inc Ratios

Theravance Biopharma Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

TBPH
Cash Ratio 8.81
Current Ratio 9.48

Theravance Biopharma Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TBPH
ROA (LTM) -5.32%
ROE (LTM) 14.03%

Theravance Biopharma Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TBPH
Debt Ratio Lower is generally better. Negative is bad. 0.44
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.56

Theravance Biopharma Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TBPH
Trailing PE 35.11
Forward PE 16.34
P/S (TTM) 12.62
P/B 4.36
Price/FCF NM
EV/R 9.07
EV/Ebitda 13.73
PEG NM

FAQs

What is Theravance Biopharma Inc share price today?

Theravance Biopharma Inc (TBPH) share price today is $20.38

Can Indians buy Theravance Biopharma Inc shares?

Yes, Indians can buy shares of Theravance Biopharma Inc (TBPH) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TBPH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Theravance Biopharma Inc be purchased?

Yes, you can purchase fractional shares of Theravance Biopharma Inc (TBPH) via the Vested app. You can start investing in Theravance Biopharma Inc (TBPH) with a minimum investment of $1.

How to invest in Theravance Biopharma Inc shares from India?

You can invest in shares of Theravance Biopharma Inc (TBPH) via Vested in three simple steps:

  • Click on Sign Up or Invest in TBPH stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Theravance Biopharma Inc shares
What is Theravance Biopharma Inc 52-week high and low stock price?

The 52-week high price of Theravance Biopharma Inc (TBPH) is $20.79. The 52-week low price of Theravance Biopharma Inc (TBPH) is $7.9.

What is Theravance Biopharma Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Theravance Biopharma Inc (TBPH) is 35.1053

What is Theravance Biopharma Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Theravance Biopharma Inc (TBPH) is 4.36

What is Theravance Biopharma Inc dividend yield?

The dividend yield of Theravance Biopharma Inc (TBPH) is 0.00%

What is the Market Cap of Theravance Biopharma Inc?

The market capitalization of Theravance Biopharma Inc (TBPH) is $1.01B

What is Theravance Biopharma Inc's stock symbol?

The stock symbol (or ticker) of Theravance Biopharma Inc is TBPH

How Can Investors Use Theravance Biopharma Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Theravance Biopharma Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Theravance Biopharma Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Theravance Biopharma Inc shares for Indian investors?

When investing in Theravance Biopharma Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Theravance Biopharma Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Theravance Biopharma Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Theravance Biopharma Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Theravance Biopharma Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top